101 related articles for article (PubMed ID: 2574891)
1. The Psychiatric Symptom Assessment Scale (PSAS).
Bigelow LB; Berthot BD
Psychopharmacol Bull; 1989; 25(2):168-73. PubMed ID: 2574891
[No Abstract] [Full Text] [Related]
2. The relationship of the brief psychiatric rating scale to neuropsychological deficits in phenothiazine-treated schizophrenics.
Golden CJ; Carpenter B; Wilkening G; Ruedrich S; Chu CC; Graber B
Psychopharmacol Bull; 1983; 19(3):513-7. PubMed ID: 6138799
[No Abstract] [Full Text] [Related]
3. Empirical evaluation of the factorial structure of clinical symptoms in schizophrenia: effects of typical neuroleptics on the brief psychiatric rating scale.
Harvey PD; Davidson M; White L; Keefe RS; Hirschowitz J; Mohs RC; Davis KL
Biol Psychiatry; 1996 Oct; 40(8):755-60. PubMed ID: 8894068
[TBL] [Abstract][Full Text] [Related]
4. The brief psychiatric rating scale: effect of scaling system on clinical response assessment.
Thompson PA; Buckley PF; Meltzer HY
J Clin Psychopharmacol; 1994 Oct; 14(5):344-6. PubMed ID: 7806691
[TBL] [Abstract][Full Text] [Related]
5. [Increased blink rate in schizophrenic patients].
Mackert A; Woyth C; Flechtner KM; Frick K
Nervenarzt; 1990 Jul; 61(7):426-30. PubMed ID: 1975431
[No Abstract] [Full Text] [Related]
6. Symptoms in neuroleptic-naive, first-episode schizophrenia: response to risperidone.
Kopala LC; Fredrikson D; Good KP; Honer WG
Biol Psychiatry; 1996 Feb; 39(4):296-8. PubMed ID: 8645777
[No Abstract] [Full Text] [Related]
7. [Deficit schizophrenias].
Puech AJ
Encephale; 1996 Jun; 22 Spec No 2():1. PubMed ID: 8767033
[No Abstract] [Full Text] [Related]
8. [Depressive symptoms in schizophrenia].
Gerard A
Encephale; 1998 Jul; 24 Spec No 1():24-6. PubMed ID: 9809250
[No Abstract] [Full Text] [Related]
9. Novel neuroleptics in schizophrenia: theory and clinical relevance.
Remington GJ
Can J Psychiatry; 1994 Nov; 39(9 Suppl 2):S43-5. PubMed ID: 7533050
[No Abstract] [Full Text] [Related]
10. Management of treatment refractory schizophrenia.
Morrison DP
Br J Psychiatry Suppl; 1996 Dec; (31):15-20. PubMed ID: 8968651
[No Abstract] [Full Text] [Related]
11. Subjective assessments of the quality of life, well-being and self-efficacy in patients with schizophrenia.
Chino B; Nemoto T; Fujii C; Mizuno M
Psychiatry Clin Neurosci; 2009 Aug; 63(4):521-8. PubMed ID: 19531107
[TBL] [Abstract][Full Text] [Related]
12. The effect of augmentation with moclobemide on symptoms of schizophrenia.
Silver H; Aharon N; Hausfater N; Jahjah N
Int Clin Psychopharmacol; 1999 May; 14(3):193-5. PubMed ID: 10435775
[TBL] [Abstract][Full Text] [Related]
13. [Comparison of 2 depression scales and their relationship with negative and akinetic symptoms in stabilized schizophrenic patients].
Langlois-Thery S; Dollfus S; Lesieur P; Petit M
Encephale; 1994; 20(5):487-93. PubMed ID: 7828511
[TBL] [Abstract][Full Text] [Related]
14. [Weight gain and clozapine].
Jalenques I; Tauveron I; Albuisson E; Audy V
Encephale; 1996 Oct; 22 Spec No 3():77-9. PubMed ID: 8954282
[No Abstract] [Full Text] [Related]
15. Experience with a drug-free month in schizophrenic outpatients.
Heinrichs DW; Carpenter WT
Psychopharmacol Bull; 1985; 21(1):117-9. PubMed ID: 2858904
[No Abstract] [Full Text] [Related]
16. Frontal lobe tasks, antipsychotic medication, and schizophrenia syndromes.
Himelhoch S; Taylor SF; Goldman RS; Tandon R
Biol Psychiatry; 1996 Feb; 39(3):227-9. PubMed ID: 8837987
[No Abstract] [Full Text] [Related]
17. [Effect of neuroleptics on depressive symptoms].
Tabeze JP
Encephale; 1998 Jul; 24 Spec No 1():38-41. PubMed ID: 9809254
[No Abstract] [Full Text] [Related]
18. The treatment of negative symptoms: pharmacological and methodological issues.
Carpenter WT
Br J Psychiatry Suppl; 1996 May; (29):17-22. PubMed ID: 8733819
[No Abstract] [Full Text] [Related]
19. Definitions of response and remission in schizophrenia: recommendations for their use and their presentation.
Leucht S; Davis JM; Engel RR; Kissling W; Kane JM
Acta Psychiatr Scand Suppl; 2009; (438):7-14. PubMed ID: 19132961
[TBL] [Abstract][Full Text] [Related]
20. Schizophrenia, violence, clozapine and risperidone: a review. The Special Hospitals Treatment Resistant Schizophrenia Research Group.
Br J Psychiatry Suppl; 1996 Dec; (31):21-30. PubMed ID: 8968652
[No Abstract] [Full Text] [Related]
[Next] [New Search]
